Literature DB >> 19378629

Age-related macular degeneration: a guide for the primary care physician.

Ribhi Hazin1, P David Freeman, Malik Y Kahook.   

Abstract

Age-related macular degeneration (AMD) is the leading cause of visual loss in Americans over the age of 50 years. AMD often results in profound disability due to the disease destroying the macula, the part of the retina responsible for central visual acuity and color vision. Risk factors for AMD include age greater than 50, female gender, Caucasian race, cigarette smoking, and family history of AMD. African Americans and other racial or ethnic groups can be affected by AMD. Although there is no cure for AMD, early diagnosis and treatment may slow disease progression and minimize irreversible visual dysfunction. Individuals suffering from central vision loss from AMD often retain peripheral vision. These affected individuals can benefit from low vision therapy, visual rehabilitation, or both to maintain or enhance activities of daily living.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19378629     DOI: 10.1016/s0027-9684(15)30825-7

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  4 in total

1.  Low-fluence photodynamic therapy combinations in the treatment of exudative age-related macular degeneration.

Authors:  Taylan Ozturk; Hakan Oner; Ali Osman Saatci; Suleyman Kaynak
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  Adenovirus vectors targeting distinct cell types in the retina.

Authors:  J Harry Sweigard; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

3.  Low-vision intervention in individuals with age-related macular degeneration.

Authors:  Sarika Gopalakrishnan; Saranya Velu; Rajiv Raman
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

4.  Prevalence and determinants of age-related macular degeneration in the 50 years and older population: a hospital based study in Maharashtra, India.

Authors:  Sucheta R Kulkarni; Supriya R Aghashe; Rajiv B Khandekar; Madan D Deshpande
Journal:  Indian J Ophthalmol       Date:  2013-05       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.